No Routine Cancer Screening Option? New MCED Tests May HelpApril 15, 2024Preventive CarePractice ManagementPatient & Survivor CareRenal Cell CarcinomaSarcoma & GISTNonmelanoma Skin CancerNeuro-oncology
Ovarian Cancer: Another Promising Target for Liquid BiopsyApril 15, 2024Gynecologic CancerPreventive CarePatient & Survivor Care
Do Real-World Data Support Omitting Sentinel Lymph Node Biopsy in Early Stage Breast Cancer?April 15, 2024Breast Cancer
Oncologists Voice Ethical Concerns Over AI in Cancer CareApril 12, 2024Practice ManagementBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary Cancer
Further Support for CRC Screening to Start at Age 45: Meta-AnalysisApril 12, 2024GastroenterologyPreventive CareGastrointestinal Cancer
GLP-1 Receptor Agonists Don’t Raise Thyroid Cancer RiskApril 12, 2024Head & Neck/Thyroid CancersPatient & Survivor Care
What to Know About the Next-Gen FIT for CRC ScreeningApril 12, 2024Gastrointestinal CancerGastroenterologyPreventive CarePatient & Survivor Care
Consider Skin Cancer, Infection Risks in Solid Organ Transplant RecipientsApril 12, 2024Nonmelanoma Skin CancerMelanomaMixed Topics
Circulating Tumor DNA Predicts Early Treatment Response in Patients With HER2-Positive CancersApril 12, 2024Patient & Survivor CareBreast CancerGastrointestinal CancerCNS/Brain CancerGynecologic CancerGenitourinary CancerHead & Neck/Thyroid Cancers
Liquid Biopsy Has Near-Perfect Accuracy for Early Pancreatic CancerApril 11, 2024Gastrointestinal CancerPatient & Survivor CarePreventive CareGastroenterology
Repeat MCED Testing May ID Early-Stage and Unscreened CancersApril 10, 2024Preventive CareBreast CancerCNS/Brain CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersGastrointestinal Cancer
ImPrint Identifies Patients With Breast Cancer Likely to Respond to Neoadjuvant ImmunotherapyApril 10, 2024Breast CancerMetastatic Breast CancerPatient & Survivor Care
